Basic HTML Version
Annual Report 2012 KPJ Healthcare Berhad
144
Directors’ report (continued)
The directors declared fourth interim single tier dividend of 4.0 sen per share on 650,349,000 ordinary shares amounting to RM26,013,960 on 4 March 2013.
The directors do not propose any final dividend for the financial year ended 31 December 2012.
Issue of shares
During the financial year, the Company increased its issued and paid-up share capital from RM292,492,000 to RM323,091,000, through the issuance of
61,198,000 ordinary shares of RM0.50 each, by way of the conversion of warrants at an exercise price of RM1.70 per share.
The new ordinary shares issued during the financial year rank pari passu in all respects with the existing ordinary shares of the Company.
Directors
The names of the directors of the Company in office since the date of the last report and at the date of this report are:
Dato’ Kamaruzzaman Abu Kassim
(Chairman)
Amiruddin Abdul Satar
(Appointed as Managing Director on 1 Jan 2013)
Datin Paduka Siti Sa’diah Sh Bakir
(Resigned as Managing Director and appointed as Non-Executive Director on 1 Jan 2013)
Datuk Dr Hussein Awang
Datuk Azzat Kamaludin
Zainah Mustafa
Ahamad Mohamad
Dr Kok Chin Leong
Dr Yoong Fook Ngian
Rozan Mohd Sa’at
Abd Razak Haron
In accordance with Article 96 of the Company’s Articles of Association, Dato’ Kamaruzzaman Abu Kassim, Ahamad Mohamad and Dr Kok Chin Leong, retire at the
forthcoming Annual General Meeting and being eligible, offer themselves for re-election.
Pursuant to Section 129(6) of the Companies Act, 1965, Datuk Dr Hussein Awang and Dr Yoong Fook Ngian, who are above the age of seventy (70) retire at the
forthcoming Annual General Meeting and will be proposed for re-appointment as directors and to hold office until the next Annual General Meeting.
Directors’ benefits
Neither at the end of the financial year, nor at any time during that year, did there subsist any arrangement to which the Company was a party, whereby the directors
might acquire benefits by means of the acquisition of shares in or debentures of the Company or any other body corporate, other than those arising from the share
options granted under the Employee Share Option Plan.
Since the end of the previous financial year, no director has received or become entitled to receive a benefit (other than benefits included in the aggregate amount
of emoluments received or due and receivable by the directors or the fixed salary of a full-time employee of the Company as shown in Note 8 to the financial
statements) by reason of a contract made by the Company or a related corporation with any director or with a firm of which he is a member, or with a company in
which he has a substantial financial interest, except as disclosed in Note 33 to the financial statements.